Technical Analysis for VPRO - Viropro Inc

Grade Last Price % Change Price Change
grade D 0.0012 0.00% 0.0000
VPRO closed unchanged on Friday, September 20, 2019, on 53 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical VPRO trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish 20.00%
Wide Bands Range Expansion 20.00%
Gapped Down Weakness 20.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction 20.00%

Older signals for VPRO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Viropro Inc., through its subsidiaries, engages in the contract research, development, and manufacture of biotherapeutic proteins for the treatment of various diseases. The company is also involved in the transfer of its proprietary technologies for industrial production of biogeneric therapeutic proteins for the treatment of various diseases, such as cancer, diabetes, hepatitis, or multiple sclerosis. It manufactures biologics drugs, including bio-similars for pre-clinical, and Phase I, II, and III clinical trials; offers its clients with supply of mammalian cell proteins, such as monoclonal antibodies or recombinant proteins, or other cell-derived products; owns three clones that include two in insulin therapy and one for cancer therapy; and provides contractual research and manufacturing services to biotech and biopharmaceutical companies. The company's contractual work activities include cloning, sequencing, purifying, developing, validating, and producing biopharmaceutical products and sub-products. It has operations in Canada, the United Kingdom, and Malaysia. Viropro Inc. has collaboration agreement with Oncobiologics, Inc. to manufacture and commercialize monoclonal antibody products. The company is based in San Jose, California. Viropro Inc. is a subsidiary of Alpha Biologics Limited.
Biotechnology Cancer Biopharmaceutical Life Sciences Biology Diabetes Diseases Antibodies Multiple Sclerosis Cloning Hepatitis Biopharmaceutical Products Cancer Therapy Treating Cancer Monoclonal Antibody Manufacturing Services Recombinant Dna Treatment Of Various Diseases Biosimilar Monoclonal Antibody Products Pharming
Is VPRO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.01
52 Week Low 0.0005
Average Volume 141,112
200-Day Moving Average 0.0019
50-Day Moving Average 0.0013
20-Day Moving Average 0.0012
10-Day Moving Average 0.001
Average True Range 0.0007
ADX 35.09
+DI 21.4286
-DI 37.1429
Chandelier Exit (Long, 3 ATRs ) -0.0005
Chandelier Exit (Short, 3 ATRs ) 0.0026999999999999999
Upper Bollinger Band 0.0018
Lower Bollinger Band 0.0006
Percent B (%b) 0.5
BandWidth 100.0
MACD Line -0.0002
MACD Signal Line -0.0001
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0021
Resistance 3 (R3) 0.0020 0.0016 0.0020
Resistance 2 (R2) 0.0016 0.0014 0.0017 0.0019
Resistance 1 (R1) 0.0014 0.0012 0.0015 0.0015 0.0018
Pivot Point 0.0010 0.0010 0.0011 0.0011 0.0010
Support 1 (S1) 0.0008 0.0008 0.0009 0.0009 0.0006
Support 2 (S2) 0.0004 0.0006 0.0005 0.0005
Support 3 (S3) 0.0002 0.0004 0.0005
Support 4 (S4) 0.0003